Biotech VC Funds

PSV Tech01 is the flagship venture capital fund of PreSeed Ventures (PSV) — Denmark's largest and most experienced pre-seed investor. PreSeed Ventures was founded in 2000 at DTU (Technical University of Denmark), where it originated as DTU Innovation, and is still owned by DTU, headquartered in Kongens Lyngby in Greater Copenhagen. PSV operates as a 'venture house' — a coordinated collection of funds and platforms designed to act as the first institutional investor on the cap table for Danish and Southern Swedish startups. PSV Tech01 is a EUR 55 million software-oriented pre-seed fund launched in December 2021 to back approximately 40 early-stage startups over four years. PSV Hafnium — Denmark's first dedicated deep-tech venture fund, launched in 2024 with a EUR 80 million hard cap — targets science-based cleantech, healthtech, and next-generation industrial solutions, with a first close of EUR 38.1 million in October 2024 backed by the European Investment Fund and EIFO. Since inception in 2000, PSV has financed and assisted over 400 startups and made 141 disclosed investments; more than 75% of portfolio companies go on to raise follow-on capital. Notable portfolio successes include Vivino, Trustpilot, Lunar, Seaborg Technologies, and Glycom. The firm leads rounds at pre-seed and seed and operates through a broad co-investor network including Creandum, Seed Capital, Northzone, Vækstfonden, Howzat Partners, Merck Ventures, and the Lundbeck Foundation. PSV's DTU ownership gives it a structurally privileged position in the Danish innovation ecosystem: the university relationship generates direct access to research commercialization opportunities, faculty founders, and student entrepreneurs before they enter the broader market. This pipeline advantage compounds over time and has enabled PSV to be the defining first investor in some of Denmark's most successful technology companies.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Puhua Capital, established in 2004 and based in Hangzhou, China, is a prominent venture capital firm with a focus on early and mid-stage investments in cutting-edge technology sectors. The firm is particularly active in industries such as healthcare, semiconductors, energy, and artificial intelligence. Puhua Capital's investment strategy revolves around identifying high-potential startups in sectors like biotechnology, clean energy, and advanced manufacturing, often engaging in rounds ranging from $15M to $50M. Notably, the firm has been involved in significant deals such as investments in Pudu Robotics, a leader in autonomous delivery robots, and Pony.ai, an autonomous driving technology company. Puhua Capital also emphasizes innovation within health and deep tech, backing companies like Creavo Medical Technologies and Laser Link, which specialize in medical devices and optical communication technology, respectively. Led by CEO Shen Qinhua, the team at Puhua Capital leverages their extensive industry knowledge to help scale their portfolio companies both within China and internationally. The firm has a strong track record of successful exits, including IPOs, and maintains a forward-looking approach, investing in technologies poised to transform industries on a global scale​.

Pureos Bioventures is a venture capital firm focusing on investing in innovative biopharmaceutical companies. Pureos Bioventures targets early-stage to growth-stage companies developing novel therapeutic approaches and technologies in the life sciences sector. The firm is particularly interested in startups that aim to address unmet medical needs and provide transformative treatments for patients. Pureos Bioventures is known for its strategic investments and active involvement in the development of its portfolio companies. The firm leverages its extensive network and deep industry expertise to support the growth and success of the startups it invests in. The investment strategy of Pureos Bioventures typically involves significant initial investments, with the potential for follow-on funding as companies progress. This approach allows the firm to nurture and support its portfolio companies through various stages of development, from early research to clinical trials and commercialization. The team at Pureos Bioventures comprises experienced professionals with backgrounds in biotechnology, pharmaceuticals, and venture capital. Their combined expertise enables them to identify promising investment opportunities and provide valuable guidance and support to their portfolio companies. For startups looking to engage with Pureos Bioventures, it is essential to demonstrate innovative and impactful therapeutic solutions with strong potential for clinical and commercial success. Emphasizing a clear path to address unmet medical needs and the potential for significant patient impact will be key in attracting investment from Pureos Bioventures.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

Pymwymic, founded in 1994, is a Netherlands-based impact investment cooperative that channels capital into businesses driving positive environmental and social change. Known for its pioneering role in European impact investing, Pymwymic's mission is to blend financial returns with measurable impact, focusing primarily on sectors such as sustainable agriculture, ecosystem restoration, and food systems. Their investments are managed through SDG-aligned sub-funds like the Healthy Food Systems Impact Fund, which targets startups transforming the global food industry through sustainable technologies. Over the years, Pymwymic has invested more than €60 million into innovative companies, helping them scale while maintaining their social missions. Recent investments include Aurea Imaging, which enhances environmental monitoring using AI, and Weenat, which focuses on data-driven water management​. With over 150 co-owners, Pymwymic operates as a cooperative, bringing together families, entrepreneurs, and institutional investors to co-develop impactful ventures. Their approach emphasizes impact governance, requiring companies to meet specific KPIs related to social and environmental outcomes. This community-driven structure allows Pymwymic to foster deep relationships with its portfolio companies, ensuring that the businesses stay committed to their missions as they grow and that profit never overshadows the planet​.

Qbic, established in 2012 and headquartered in St-Denijs-Westrem, Belgium, is a venture capital fund focused on early-stage investments, particularly in spin-offs from universities, research institutions, and hospitals. The fund supports startups in sectors such as deeptech, biotech, medtech, and software. Qbic has made significant contributions to transforming technological breakthroughs into sustainable businesses. Notable investments by Qbic include Theratrame, which focuses on cancer therapies, Animab, which develops alternatives to antibiotics for animals, and VoxelSensors, which specializes in 3D perception sensors for extended reality applications. Additionally, their portfolio includes companies like AmphiStar in the biotechnology field and Weave.ly in software development. Qbic manages around €200 million across its various funds, with Qbic III recently raising €88.5 million to continue supporting innovative spin-offs. The fund's strategic partners include major Belgian universities and research institutions, providing a strong pipeline of high-potential startups. The team at Qbic, led by Managing Partner Sofie Baeten, is dedicated to fostering technological innovation and supporting the growth of their portfolio companies.

Qiming Venture Partners, founded in 2006, is a leading venture capital firm with a strong focus on investments in the technology, consumer, and healthcare sectors. The firm operates with a significant presence in China and the United States, managing over $9.5 billion in capital across 18 funds. Qiming has an impressive portfolio of successful investments, including prominent companies such as Xiaomi, Bilibili, Meituan, and Mindray. These companies highlight Qiming's ability to identify and support high-potential startups that grow into industry leaders. The firm typically invests in early and growth-stage companies, emphasizing sectors like internet and consumer products, healthcare, and technology​​. The investment strategy at Qiming is comprehensive, often providing extensive support to portfolio companies through strategic guidance and leveraging a vast network. Key team members, like Bonnie Wang, focus on internet and consumer investments and have been recognized for their contributions to the venture capital industry​​. With a commitment to fostering innovation and growth, Qiming Venture Partners continues to play a crucial role in the global venture capital landscape, especially within the dynamic markets of China and the U.S.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Quake Capital, founded in 2016, is a venture capital firm and accelerator headquartered in Seattle, Washington, with a strong presence in New York and Los Angeles. The firm focuses on seed-stage investments, offering substantial support to new and early-stage ventures across a wide range of industries. Through their accelerator program, Quake Capital provides startups with resources, mentorship, and funding to help them grow and succeed. The firm has made over 300 investments in various sectors, including digital health, fintech, AR/VR, gaming, and e-commerce. Notable portfolio companies include NOCD, which offers online therapy for OCD; Blok Party, a platform combining physical, digital, and social play; Vyrill, a user-generated video content discovery and marketing platform; and Grain, which helps individuals build credit through savings. Quake Capital's investment strategy is industry-agnostic, emphasizing innovation and potential for growth. They typically invest $100,000 to $150,000 in each startup that completes their accelerator program. The firm’s founders, Glennon Argenbright, Chad Burgess, Adam Cragg, and Brandon Maier, bring extensive experience in venture capital and entrepreneurship, providing valuable insights and support to their portfolio companies.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quam Venture Capital (Quam VC LLP) is a London-based, FCA-regulated venture capital investment advisor founded in 2012. Rather than managing a single pooled fund, the firm serves as investment advisor to a consortium of general partners overseeing three parallel Europe-domiciled venture funds alongside a portfolio of bespoke special purpose vehicles, allowing flexible co-investment across themes and deal sizes. The five-person team draws on backgrounds across investment banking, finance, law, marketing, management consulting, and technology. Investment sizes range from approximately 500,000 euros for innovative early-stage concepts to around 3 million euros for teams with early revenue traction, scaling to roughly 10 million euros for follow-on support as portfolio companies mature. The firm's thematic mandate is broad: artificial intelligence, space ventures, clean technology and renewable energy, biotechnology, blockchain and distributed ledger technologies, cybersecurity, quantum computing, stem cell and nanotechnology, virtual reality, transportation, and infrastructure. Geographic coverage spans Europe, North America, and Latin America, giving Quam the flexibility to engage with global-ambition founders regardless of domicile. The team includes Josh, an FCA-accredited investment advisor and strategic lead; Vic, a partner with 30-plus years in real estate and 25 years spanning brand marketing, property management, and venture capital; Diogo, who sources and evaluates technology-based startups across biotech, ICT, energy, and tourism; and Andy, who serves on the Investment Committee. The SPV-led structure and preference for discreet deployments rather than publicized fund announcements reflects the firm's focus on bespoke deal-by-deal engagements with strategic investors.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

QIC (Queensland Investment Corporation) is a prominent institutional investment manager based in Queensland, Australia. Established in 1991, QIC manages diverse multi-asset portfolios on behalf of the Queensland Government and private institutional clients. The firm's investment focus spans infrastructure, real estate, private equity, private debt, and liquid markets. QIC’s long-term strategy is built around harnessing global megatrends like sustainability, climate resilience, and digital transformation to deliver robust, long-term returns for its investors. As part of its mission to foster innovation and economic growth, QIC manages the Queensland Venture Capital Development Fund (QVCDF), which was launched to bolster the state's venture capital ecosystem. The QVCDF provides matched funding and accelerator programs to support early-stage and growth-stage startups in Queensland, allowing them to scale within the state. The fund is committed to building a strong venture capital industry in Queensland by partnering with VCs such as Antler, Main Sequence, and Sprint Ventures. The QVCDF focuses on sectors like AI, climate tech, healthcare, and automation, positioning Queensland as a leader in digital healthcare and sustainability. Recent investments include backing startups like Vapar, Avarni, and Emesent, which are driving innovation in fields ranging from drone technology to climate action. With over $130 million committed to the fund, QIC is ensuring that Queensland startups have the capital and support needed to grow, scale, and make a global impact while remaining rooted in the state​.

Quest Venture Partners, based in Silicon Valley, excels in early-stage investments, typically ranging from $100,000 to $1.5 million, with a focus around $500,000. They are often the first institutional investors, backing startups in digital media, mobile, and new tech sectors. Notable investments include Amplitude, Coffee Meets Bagel, and Neurable, demonstrating their knack for identifying high-potential companies. Quest’s strategy is hands-on, supporting founders through initial growth stages with strategic guidance. They prioritize startups with innovative ideas and strong teams, fostering a collaborative environment to drive success. The firm is led by Managing Partners Andrew Ogawa, Maarten 't Hooft, and Marcus Ogawa, who bring diverse expertise from Daimler AG, Google, and the mobile/digital media sectors, respectively. This blend of experience helps Quest provide substantial value and insight to their portfolio companies. Quest Venture Partners is globally focused, leveraging their Silicon Valley base to invest in scalable, innovative startups worldwide. Their active involvement and strategic approach make them a preferred partner for early-stage ventures aiming for significant impact.

Quest Ventures is a leading venture capital firm focused on driving the digital economy across Asia. Founded in 2011 by James Tan and Wang Yunming, Quest Ventures invests primarily in early-stage startups within sectors such as artificial intelligence, e-commerce, fintech, logistics, media, and more. The firm is renowned for being one of the first investors in many startups, providing the critical early funding that enables these companies to scale and disrupt their industries. With its headquarters in Singapore and a significant presence in Southeast Asia, Quest Ventures has supported over 100 companies, including notable names like Carousell, ShopBack, 99.co, and StyleTheory. The firm's investment strategy includes thematic funds such as the Asia Fund, Metaverse Fund, and Decarbonisation Fund, focusing on areas like Web 3.0 technologies and environmental sustainability. Quest Ventures also operates investment syndicates, allowing accredited investors to participate in funding rounds of promising startups. This approach has enabled Quest Ventures to build a robust network of mentors, executives, and investors who provide strategic support and market insights to portfolio companies.

Quidnet Ventures is a New Zealand deep-tech venture capital firm founded in 2019 and based in Auckland. The firm invests exclusively in scalable, capital-efficient New Zealand-based businesses with global ambition from day one, spanning material science, medical devices, agritech, data services, IoT, climate tech, biotech, semiconductors, and AI. Quidnet is led by Founder and General Partner Dr. Mark Bregman, a physicist with 30 years of technology experience including 16 years leading research and innovation at IBM and subsequent CTO-level roles at major enterprises. Quidnet leads rounds and writes seed-stage cheques of $100,000 to $500,000, with a typical average around $300,000. Fund I has been fully deployed; Fund II is targeted at approximately $25 million, roughly five times the size of Fund I. The firm has 8 portfolio companies to date. Notable investments include Marama Labs (deep-tech spectroscopy), Ambit (AI conversational platform), Arcanum AI (AI automation), RosterLab (workforce rostering software), Litmaps (science research software), and Advemto (photonics technology). Quidnet is affiliated with Icehouse Ventures' broader New Zealand startup platform. Dr. Bregman's differentiated value proposition is opening US distribution channels, advisor networks, and talent pools to Kiwi deep-tech companies — a form of market-access support that few New Zealand investors can credibly deliver. The firm works closely with founders for years prior to investment, establishing trust and technical alignment before committing capital. This patient, relationship-first approach, combined with Silicon Valley-grade operating experience applied to the New Zealand ecosystem, defines Quidnet's edge as the country's leading deep-tech seed investor.

Quiet Capital, founded in 2017 and based in San Francisco, is a technology-focused venture capital firm. They invest in early-stage companies, spanning sectors such as fintech, software, cybersecurity, health and wellness, and AI. Their diverse portfolio includes notable companies like MoonPay, DuckDuckGo, Mercury, Reddit, and Substack. Quiet Capital typically invests from pre-seed to Series D stages, aiming to support remarkable founders from day zero. They have made 263 investments and achieved 11 notable exits, including Reddit and Atom Finance. Their investment strategy is centered on backing innovative technologies and scalable business models across a variety of industries. The firm is managed by a team of experienced partners including Ben Mahdavi, Co-Founder and Managing Partner, and Christopher Capozzi, Partner and CFO. They are known for their hands-on approach, providing strategic support and leveraging their extensive network to help portfolio companies grow. For startups looking to engage with Quiet Capital, demonstrating strong innovation, scalability, and a clear market need is essential. Connecting through their network or via their platform can improve the chances of securing investment.

Qure Ventures is Israel's first venture capital fund dedicated exclusively to digital health, founded in 2012 and headquartered in Herzliya. In November 2016 the firm launched a flagship $50 million vehicle in partnership with equity crowdfunding platform OurCrowd, sometimes branded as OurCrowd Qure. The fund invests predominantly in Israel-based digital health startups across Seed, Series A, and selective Series C follow-ons, with an explicit thesis to fund deep-tech solutions that improve patient care, reduce healthcare delivery costs, create data transparency, and empower health consumers. The fund is led by Managing Partners Dr. Yossi Bahagon — founder and CEO of Luminox Health, acquired by OurCrowd, and a recognized digital health expert — and Allen Kamer, co-founder of Humedica, which was acquired by UnitedHealth Group in 2013. Across 12 portfolio companies, notable names include Tyto Care (remote clinical exam kit), DarioHealth (IPO), Zebra Medical Vision (acquired by Nanox), and Carevive, which was acquired by Health Catalyst in June 2024. The portfolio has produced one IPO and three acquisitions in total. Qure's defining operating philosophy is hands-on engagement: roughly 70 percent of team time is devoted to supporting portfolio companies on strategy, business development, growth, and follow-on fundraising. Strategic partnerships spanning consumer, provider, payer, and pharma channels help portfolio companies access clinical-trial pipelines and commercial distribution faster than they could independently. This partnership-intensive model, combined with deep domain expertise in Israeli health technology, positions Qure as a category specialist in one of the world's leading digital health ecosystems.

R/GA Ventures is the investment and innovation arm of R/GA, a global digital agency. Founded in 2013, the firm supports early-stage startups through accelerator programs and offers financial, creative, and relationship capital. Notable investments include Latch, Happy Returns, and Transmit.Live. R/GA Ventures focuses on sectors such as IoT, commerce, retail, marketing tech, sports, and media tech. Their unique approach includes connecting startups with R/GA's extensive global network, providing strategic guidance and resources to help startups scale and succeed.

R3i Ventures is the venture arm of R3i Capital, a female-owned venture capital and advisory firm founded in 2021 with its primary headquarters in Singapore and additional presence in Luxembourg and Silicon Valley. The firm focuses on patent-backed artificial intelligence and emerging-technology companies, investing globally across Asia-Pacific, Europe, and the Americas. R3i is led by Founder and General Partner Leesa Soulodre, alongside Prof. Marianne Winslett, who brings 30-plus years in trustworthy systems, data science, and high-performance computing and served as founding director of the Advanced Digital Sciences Center in Singapore from 2009 to 2013. R3i Future Fund LP is a roughly $50 million deeptech seed-stage vehicle targeting climate and healthcare opportunities via accelerator programs in Singapore, Luxembourg, and Texas. Sector focus spans applied AI, space, security, renewable energy, medtech, watertech, agriculture, advanced manufacturing, robotics, and semiconductors. Across its broader platform, R3i reports $184 million invested into 39 portfolio companies, $156 million returned across 16 exits, and approximately $2.4 billion of capital mobilized alongside $1.1 billion in non-dilutive grant funding. Notable portfolio companies include Quantum Brilliance (room-temperature quantum computing), ViewMind (brain-health diagnostics), and Prosoma (digital therapeutics). Ecosystem partners include Enterprise Singapore, Microsoft, Amazon, and NVIDIA. In April 2024, R3i launched R3i Frontier, a Venture Partner Investment Program designed for seven angel investors and emerging managers building track records in climate-deeptech. This platform extension reflects the firm's broader mission to build the funding infrastructure for frontier technology across underserved regions and asset classes, combining direct investment with ecosystem-development activities that amplify its capital with institutional and government partnerships.

R42 Group is a venture capital firm based in Stanford, California, with a focus on deep science, artificial intelligence, and biotechnology. Established by Dr. Ronjon Nag, a seasoned AI entrepreneur with exits to companies like Motorola and Apple, R42 primarily invests in early-stage companies and supports them through a unique combination of financial backing and expert advisory. R42 has a hands-on approach, working closely with founders from the concept stage to growth, helping them build sustainable, impactful businesses in emerging fields such as AI, longevity, and deep tech. R42's portfolio includes companies such as Fountain Therapeutics, Healx, and Rubedo Life Sciences, all of which are innovating within the biotech and life sciences spaces. The firm also invests in early-stage funds that align with its values and frequently co-invests alongside these funds in promising startups. With a strong team of experts, including academics and industry veterans, R42 provides more than just capital—it offers strategic guidance, mentorship, and deep technical expertise to help companies succeed in highly specialized markets. In addition to investing, R42 runs the R42 Institute, which focuses on educating entrepreneurs and the broader community on AI, biotechnology, and longevity. Through its educational programs and investment strategies, R42 is committed to shaping the future of science and technology​.

RA Capital Management is a Boston-based venture capital and investment firm focused primarily on healthcare and life sciences. Founded in 2002, the firm invests across multiple stages, from seed funding to IPO, in companies developing drugs, medical devices, diagnostics, and research tools. RA Capital is known for its deep scientific and market expertise, facilitated by its internal research division, TechAtlas, which provides insights into competitive landscapes and helps guide investment decisions. The firm supports startups through its RAVen incubator, offering resources beyond capital, including strategic guidance, technology transfer, and executive recruitment. RA Capital has a strong commitment to innovation in human health, working closely with academics, entrepreneurs, and executives to bring groundbreaking therapies and technologies to market. Some notable portfolio companies include Moderna, Natera, and Peloton Therapeutics. RA Capital’s approach emphasizes evidence-based investing, focusing on creating value through informed decision-making and long-term growth.

Raba Capital, also known as The Raba Partnership, is a venture capital firm focused on early-stage investments in software and internet companies within the African technology ecosystem. Established in 2019 and headquartered in Cape Town, South Africa, Raba Capital aims to partner early with founders to help them build companies that solve real-world problems and generate significant returns. Notable investments in their portfolio include Flutterwave, a payment processing solution that became a unicorn in 2021, and Yoco, a merchant payments platform based in South Africa. Other significant investments include Lori Systems, a logistics marketplace, and Twiga, a digital grocery platform. Raba Capital focuses heavily on fintech, logistics, and healthcare sectors. They have invested in companies such as Stitch, which provides API infrastructure for fintechs, and 54gene, which leverages African DNA for medical discoveries. The firm prides itself on aligning long-term interests with their partners and leveraging their extensive network to support portfolio companies in scaling their businesses globally.

Rachel Zoe Ventures is an early-stage venture capital firm with a focus on disruptive consumer brands and the technologies that enable them. Led by fashion icon and entrepreneur Rachel Zoe, alongside her husband Rodger Berman, the firm leverages their vast experience in the media, fashion, and tech industries to help innovative consumer startups thrive. The firm is highly involved in amplifying the brands it backs, providing not just capital but also access to a vast network and strategic guidance on scaling brand recognition and growth. The firm has made key investments in brands such as Angel City FC, Joy, Havenly, and Citizen, all of which represent the type of forward-thinking, consumer-oriented companies Rachel Zoe Ventures seeks. Their portfolio demonstrates a strong emphasis on fashion, lifestyle, and tech-enabled consumer platforms. While primarily U.S.-focused, their influence and partnerships extend globally, especially in the consumer tech space. Rachel Zoe Ventures typically leads early-stage rounds and prefers to work with brands that are ready to scale their operations and disrupt their industries. The firm’s approach prioritizes partnerships with brands that align with its founders’ expertise in fashion, lifestyle, and media. Startups looking to engage with the firm should come prepared with a clear growth story and a compelling narrative that can stand out in today’s crowded consumer market.

Radical Ventures is a venture capital firm specializing in AI-driven startups that are poised to reshape various industries. Founded by AI pioneers, the firm is headquartered in Toronto with additional offices in Palo Alto, London, and New York. Radical Ventures focuses on investing in early-stage companies that leverage artificial intelligence to create transformational solutions. Their portfolio includes innovative companies like Waabi, which is developing next-generation self-driving technology, and Cohere, which works on advanced natural language processing. Other notable investments include Aspect Biosystems in biotechnology, ClimateAi for climate planning, and Signal 1, which provides real-time insights to healthcare providers. Radical Ventures emphasizes supporting their portfolio companies through the Radical Velocity program, which offers curated resources, expert support, and strategic partnerships to help AI-first startups scale effectively. This program covers areas such as talent acquisition, compute and technology needs, brand and public affairs, go-to-market strategies, and finance and governance. The firm's mission is to support founders who understand the profound impact AI will have on the future, aiming to drive significant advancements in sectors like healthcare, transportation, financial services, and more.

Radicle Growth, now operating as Clay Capital, is a venture capital firm focused on early-stage investments in agriculture and food technologies. Founded in San Diego, California, Radicle Growth aims to identify and support innovative entrepreneurs and technologies that can transform the food system. They frequently collaborate with global industry leaders to host challenges that fund groundbreaking agtech and foodtech startups. Notable investments by Radicle Growth include MycoTechnology, BlueNalu, Pluton Biosciences, and Phospholutions. MycoTechnology, a pioneer in fungal fermentation, won the $1 million growth-stage investment in the Radicle Protein Challenge by Syngenta. BlueNalu, focused on cell-based seafood, secured a $250,000 early-stage investment in the same challenge. Pluton Biosciences and Phospholutions were the winners of the Radicle Carbon & Soil Challenge by UPL, receiving $1 million and $250,000 respectively, to advance their innovative solutions in carbon sequestration and sustainable phosphorus use. Radicle Growth’s strategy involves not only funding but also providing startups with access to their extensive network of agriculture experts and global connections to accelerate development and promote their technologies. The firm’s commitment to sustainable agriculture is reflected in its continuous efforts to drive innovation and support the development of climate-positive solutions in the food value chain.

Radius Ventures was a New York-based venture capital firm active from 1997 to 2024, focused exclusively on growth-equity and expansion-stage health and life sciences companies. Co-founded by Managing Partner Jordan S. Davis and Daniel C. Lubin, the firm took a domain-driven investment approach combined with a hands-on value-add model — pairing intellectual capital and strategic guidance with deep industry relationships to back companies transforming patient care, advancing medical innovation, and improving health outcomes. Over nearly three decades, Radius completed more than 40 portfolio investments and led rounds across medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services, and healthcare information technology. The firm realized 33 or more exits, including 3 IPOs and 21 acquisitions. Marquee outcomes include Conor Medsystems (IPO 2004, subsequently acquired by Johnson and Johnson in 2007 for $1.4 billion at $33.50 per share), Tactile Medical (IPO July 2016, ranked first in share-price performance among commercial-stage medtech IPOs for over two years), Tabula Rasa Healthcare (IPO September 2016, ranked first among commercial-stage healthcare IT and services IPOs for over two years), and BioStorage Technologies, acquired by Brooks Automation. The flagship Radius Venture Partners III, LP achieved top-quartile performance per the Cambridge Associates Q3 2024 Venture Capital Index. Radius formally wound down in 2024 after the final portfolio exit, EndoGastric Solutions, in July of that year. Jordan Davis now leads JSD Capital LLC advising successor vehicles, while Daniel Lubin serves as Chairman of Upsher Management Company. The firm's nearly three-decade track record stands as one of the most consistent records in dedicated health and life-sciences growth equity.

Raed Ventures is a leading early-stage venture capital firm based in Saudi Arabia, focusing on transformative tech startups across the MENA region. Established in 2015 by Omar Almajdouie and Talal Alasmari, the firm aims to back companies that disrupt traditional industries with innovative technologies. Raed Ventures’ portfolio includes over 20 fast-growing startups, such as Mrsool, Foodics, and Trella, spanning sectors like logistics, fintech, and data analytics. Raed Ventures actively leads seed and Series A rounds, particularly favoring businesses with scalable tech solutions. Their strategy goes beyond funding; they offer extensive operational support through the Raed Plus platform, providing startups with access to partnerships, discounted services, and expert advisory, saving founders up to $400,000 in costs. The firm is particularly keen on startups that drive financial inclusion, digital transformation, and operational efficiencies across industries in MENA. With an average check size undisclosed, Raed Ventures focuses on companies with strong founding teams and market potential. They are a go-to VC for entrepreneurs looking to gain traction in the region, thanks to their hands-on approach, deep industry connections, and expertise in scaling businesses. Founders looking to approach Raed Ventures should come with a clear vision for regional growth and technological impact. Key figures include Omar Almajdouie, who leads with over 17 years of experience, and Talal Alasmari, known for his expertise in team building and product design. Raed Ventures operates primarily out of Riyadh, making it a cornerstone in the Saudi and wider MENA tech ecosystem.

Rainfall Ventures is a founder-focused venture capital firm with a strong presence in New York and Los Angeles. Founded in 2011, the firm emphasizes partnering with innovative and passionate founders to help them transform industries. Rainfall Ventures typically invests in early-stage companies, including pre-seed, seed, and Series A rounds, with investment sizes ranging from $1 million to $5 million​. The firm focuses on a broad range of sectors such as analytics, AI, cloud infrastructure, social media, cryptocurrency, cybersecurity, developer tools, digital health, education, fintech, gaming, IoT, and more. This diverse investment strategy allows Rainfall to support a variety of technological advancements and innovative business models. Rainfall Ventures has a portfolio that includes notable companies like Kyra and Blloc, and they invest globally with a particular focus on the US and the UK. The firm has built a reputation for not only providing capital but also offering extensive support to their portfolio companies through mentorship and strategic guidance. The team at Rainfall Ventures includes experienced professionals like co-founder and General Partner Ron Rofé, who bring a wealth of knowledge and expertise to their investment strategy.

Rally Ventures, founded in 2012, is a venture capital firm focused on early-stage investments in business technology. The firm operates out of Menlo Park, California, and Minneapolis, Minnesota. Rally Ventures invests in entrepreneurs creating new markets or bringing transformative approaches to existing ones, with a particular emphasis on sectors like AI/ML, cybersecurity, fintech, and SaaS+. Rally Ventures has a robust portfolio of notable investments, including companies like Arctic Wolf, Bugcrowd, Harness, UiPath, Total Expert, Braze, Carbon Black, and Twistlock. These companies represent Rally Ventures' strategic focus on high-potential business technology ventures that can drive significant market impact. The firm recently closed Rally Fund V at $240 million, continuing its legacy of investing in innovative early-stage startups. Rally Ventures has built a nationwide portfolio with over $1 billion in assets under management and a strong track record of successful exits, including three IPOs. The team at Rally Ventures includes a dynamic group of over 100 Rally Tech Partners—executives, technologists, and industry leaders—who provide strategic guidance and operational support to portfolio companies. This extensive network helps Rally Ventures offer significant value beyond just financial investment.

Rapid Pioneers is a venture capital and investment firm based in Berlin, Germany, focused on building and investing in innovative consumer brands that shape the future. They have a diverse portfolio that includes companies across sectors like e-commerce, technology, and sustainability. Some of their key investments include Enpal, a leader in solar power solutions, and Animoca Brands, a Hong Kong-based venture capital firm specializing in web3 technologies. They have also backed companies like Lesara, an agile fashion retail brand, and Amorelie, a premium online brand for intimate products. Rapid Pioneers supports companies from early stages, helping them scale through strategic partnerships and hands-on involvement. They tend to invest in businesses with high growth potential in both the digital and physical goods spaces. Their portfolio highlights a strong focus on digital innovation, with investments in mobile apps, blockchain technology, and direct-to-consumer brands. The firm has made several successful exits, including Fitvia, a direct-to-consumer wellness brand, and Casacanda, a home décor e-commerce platform that was acquired by Fab.com. Rapid Pioneers emphasizes sustainability and innovation, working with brands that have a community-first approach and a vision for a greener, tech-driven future.

Rarestone Capital is a Web3-focused venture capital and investment studio that specializes in supporting innovative blockchain projects. The firm plays an active role in backing startups within the decentralized finance (DeFi), gaming, and NFT spaces, leveraging its deep industry knowledge and resources to accelerate the development of these groundbreaking technologies. Rarestone takes an incubation-first approach, offering more than just capital—it provides hands-on support through Rarestone Labs, where startups can access strategic guidance, technical expertise, and a robust network of partners and advisors. Some of the notable projects in Rarestone’s portfolio include Biconomy, Injective Protocol, and Jito Network, all of which are trailblazers in the blockchain ecosystem. Rarestone is known for investing early, often leading seed and Series A rounds, and focusing on founders with a clear vision for decentralized technologies. Their portfolio companies typically work at the intersection of crypto infrastructure and user-centric applications, aiming to make blockchain technology more accessible and scalable. Based in the UK, Rarestone has a global reach, with a particular focus on projects that drive adoption of Web3 technologies. The firm is highly selective and prefers founders who are not only technically skilled but also capable of executing disruptive ideas within the Web3 space. Startups looking to partner with Rarestone should demonstrate strong technical innovation and a clear roadmap for scaling within the blockchain ecosystem.

Remind.vc, officially known as re.Mind Capital, is a venture capital firm with a distinct focus on mental and neurological health. Launched as part of Christian Angermayer’s Apeiron Investment Group, re.Mind Capital prioritizes investments in groundbreaking companies aimed at solving global mental health challenges. The firm’s investment strategy revolves around supporting companies in neuroscience, life sciences, and digital health that offer innovative solutions to address the growing prevalence of mental health issues. Founded in 2020 and headquartered in Malta, re.Mind Capital has quickly built an impressive portfolio of pioneering companies. These include Blackrock Neurotech, which focuses on brain-computer interface technology, and other cutting-edge ventures pushing the boundaries of mental health treatment and neurotechnologies. The firm is committed to backing visionary founders who are creating transformative products and services that can fundamentally improve well-being, happiness, and freedom for millions of people worldwide. re.Mind Capital typically invests in early to mid-stage companies, offering financial backing alongside strategic guidance and a broad network of industry connections. With its strong mission-driven approach and a deep commitment to advancing the field of mental health, re.Mind Capital is positioned as a leader in the rapidly growing space of mental health innovation.

Real Ventures is Canada’s leading early-stage venture capital firm, dedicated to supporting visionary founders from the very beginning of their entrepreneurial journey. Established in 2007, Real Ventures has invested in more than 200 startups across various sectors, particularly focusing on technology-driven industries. Their portfolio features high-growth companies like Clearco, Mejuri, and BenchSci, which reflect the firm’s commitment to empowering disruptive innovations. The firm focuses primarily on Canadian startups but also supports global growth. They invest in pre-seed to Series A rounds and are deeply involved in nurturing the founders they back. Real Ventures is also known for fostering ecosystems where their portfolio companies can thrive, including co-founding Montreal’s Notman House, a hub for tech entrepreneurs. Their strategy emphasizes conscious leadership, encouraging founders to develop their mindsets as they grow their businesses. The firm’s FounderFuel accelerator program further bolsters this approach by providing startups with mentorship, resources, and community support. Founders approaching Real Ventures should demonstrate not only business potential but also a commitment to making a positive societal impact. Key figures include founding partners John Stokes, Alan MacIntosh, and JS Cournoyer, all experienced entrepreneurs and investors who are deeply embedded in Canada’s startup ecosystem. Through hands-on involvement, Real Ventures helps founders build lasting companies with the potential to reshape industries and improve the world.

Realist Ventures, established in 2018 and headquartered in Stamford, Connecticut, focuses on early-stage investments with a keen interest in sectors like SaaS, biotechnology, AI, cleantech, and underrepresented founders. The fund’s investment strategy is centered around pre-seed and seed rounds, deploying checks between $100,000 to $500,000. They emphasize realistic valuations and seek capital-efficient startups poised for scalable growth. Realist Ventures often participates in rounds but doesn’t usually lead, preferring to co-invest alongside other firms. Their team brings extensive entrepreneurial experience, with co-founder Marie Rocha playing a key role in shaping the fund's direction. Realist Ventures has backed several notable startups, including Career Karma, a platform revolutionizing career coaching, and GRID, a blockchain-based gaming company. These investments reflect the fund’s interest in cutting-edge technology and social impact. The fund primarily invests in US-based startups, but its portfolio reflects a commitment to diversity, making it an attractive partner for founders from underrepresented groups. Beyond capital, Realist Ventures provides hands-on support through mentorship and access to a vast network of industry connections. They are particularly interested in founders who can clearly articulate their vision and have a robust go-to-market strategy. For startups seeking to approach them, a realistic valuation, strong team, and clear product-market fit are essential. Realist Ventures’ investment philosophy revolves around building long-term partnerships with founders, ensuring they have both the financial and strategic backing to scale effectively.

Real Tech Fund, established in 2015 and headquartered in Tokyo, Japan, is a venture capital firm focusing on seed and early-stage investments in deep tech companies. The fund primarily targets sectors such as high tech, aerospace, AI, life sciences, and IoT. Real Tech Fund is known for its strategic partnerships with organizations like the Ministry of Economy, Trade, and Industry, and NEDO (New Energy and Industrial Technology Development Organization), aiming to solve critical societal and environmental issues through innovation. The fund's notable investments include companies like ArkEdge Space, which focuses on satellite communication and space travel, and Integriculture, an agricultural technology firm. Real Tech Fund has invested heavily in Japan, but also extends its reach to other regions, including Southeast Asia. The firm has an average investment round size of $4 million and typically leads or co-invests in 8-10 deals per year. The team at Real Tech Fund comprises experienced partners such as Mitsuru Izumo and Jonathan Hannam, who bring a wealth of expertise in various tech and investment domains. Real Tech Fund's investment approach emphasizes supporting companies that leverage advanced technology to create impactful solutions for society​.

Red Cedar Ventures is the venture investment subsidiary of the Michigan State University (MSU) Foundation. It focuses on providing early-stage funding to startups emerging from MSU’s research and entrepreneurial ecosystem, as well as other high-tech companies in Michigan. With the aim of driving economic impact in the region, Red Cedar Ventures supports innovation by helping to bridge critical funding gaps for startups, offering both pre-seed and growth-stage investments. The firm manages several funds, including a Pre-Seed Fund, Opportunity Fund I and II, and Michigan Rise Pre-Seed Fund III. These funds target startups at different stages of development, providing them with the capital needed to scale. Red Cedar Ventures also partners closely with Spartan Innovations and supports the Conquer Accelerator program, offering selected startups access to investment, mentorship, and resources to help them grow beyond the early phases. The firm’s investments span a wide range of industries, from AI to healthcare and cybersecurity, supporting startups like DeepView (smart cameras for factory inspections) and Flightpath Biosciences (therapies for pathogen-based diseases). With its roots in MSU, Red Cedar Ventures plays a key role in fostering innovation and entrepreneurship throughout Michigan.

Red Sea Ventures is a New York-based venture capital firm that focuses on early-stage investments. They primarily invest in technology-driven companies across sectors such as consumer products, fintech, healthtech, and real estate tech. Notable portfolio companies include Coinbase, Warby Parker, and Sweetgreen, showcasing their commitment to innovative and disruptive startups. Red Sea Ventures emphasizes a hands-on approach, working closely with founders to provide strategic guidance and operational support. They typically participate in Seed and Series A rounds, often leading these investments with check sizes ranging from $500k to $5 million. Their goal is to back visionary entrepreneurs who have the potential to build scalable businesses. Founded by Scott Birnbaum, Red Sea Ventures prides itself on a team of experienced professionals who bring a mix of entrepreneurial, operational, and investment expertise. They focus on the U.S. market, with a particular interest in the vibrant startup ecosystem of New York City. Entrepreneurs seeking investment from Red Sea Ventures are encouraged to have a clear and compelling business plan that demonstrates significant market opportunity and potential for growth. Warm introductions and referrals are preferred when approaching the firm, as they value strong, trusted networks.

Red Tree Venture Capital is a prominent West Coast-centric, early-stage life science venture firm founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., with managing director Jon Edwards, Ph.D. The firm raised $272 million for its inaugural fund in 2022, focusing on groundbreaking therapeutics in oncology, neurology, and immunology​. Red Tree's notable investments include Acrigen Biosciences, Alladapt Immunotherapeutics, and Ceribell, all leading innovators in gene editing, immunotherapies, and neuromodulation technologies. The firm’s strategy leverages deep relationships with top West Coast academic institutions, including Stanford and UCSF, to source pioneering scientific advancements. Red Tree predominantly leads or co-leads investment rounds, emphasizing first-in-class and best-in-class therapeutics. The firm’s leadership team, with over 60 years of combined experience, is well-versed in translating scientific innovations into successful businesses. They are supported by a scientific advisory board comprising academic luminaries and experienced biopharma executives. The firm’s investment approach is built on four pillars: a focus on West Coast innovation, early-stage investments, targeting transformative therapeutics, and concentrating on oncology, neurology, and immunology. This strategic framework positions Red Tree as a key player in advancing life science innovations that have the potential to significantly impact patient care​.

Redalpine is a leading venture capital firm based in Zurich, Switzerland, specializing in seed and early-stage investments in technology and health tech sectors. Founded in 2007, Redalpine has built a robust portfolio, investing in companies that aim to bring innovative solutions to market. Notable investments include Proxima Fusion, a startup developing next-generation fusion power plants, and Infinite Roots, a pioneer in sustainable food tech focused on mycelium fermentation, which recently raised $58 million in a record-breaking Series B round. Redalpine's investment strategy centers on supporting groundbreaking ideas with potential for significant societal impact, providing both financial backing and operational expertise. Redalpine has been instrumental in several successful exits, such as Lunaphore and natif.ai, and maintains a strong presence in Europe with additional offices in Berlin and Munsbach. The firm typically invests between CHF 500,000 to CHF 5 million per company, focusing on scalable and disruptive technologies. Led by partners like Michael Sidler, Peter Niederhauser, and Nicolas Berg, Redalpine is committed to co-creating a better future with its portfolio companies by offering deep industry knowledge, strategic support, and access to a vast network of experts and partners.

Redpoint Ventures, a prominent venture capital firm founded in 1999, is known for backing innovative startups across various stages, from seed to growth. The firm has made significant investments in leading tech companies like Netflix, Stripe, Snowflake, and Twilio, reflecting its focus on high-potential ventures in consumer, enterprise, and emerging technologies​​. Redpoint's industry focus includes software services, cloud computing, fintech, healthcare, and next-gen media. Their strategy emphasizes early-stage investments, partnering with entrepreneurs to create new markets and redefine existing ones. With an average investment round size of around $1 million, Redpoint typically takes an active role in leading these rounds, offering not just capital but strategic support​​. Geographically, Redpoint Ventures operates mainly out of the United States but has a strong presence in China through Redpoint China Ventures, which focuses on consumer and frontier tech startups​. Key team members include Jeff Brody, who co-founded the firm, and Logan Bartlett, a General Partner known for his expertise in early-growth investments. Their team is based in Menlo Park, California, and they are deeply involved in guiding startups towards successful exits, as evidenced by their numerous high-profile IPOs and acquisitions​​. For startups aiming to catch Redpoint's attention, it’s crucial to present innovative, scalable solutions and a strong market potential. They prefer approaches that showcase clear strategic alignment with their investment focus areas and demonstrate the potential for substantial growth and market impact

Redstick Ventures is an early-stage investor focused on transforming the food ecosystem. Specializing in innovations that tackle labor shortages, food waste, packaging, and food accessibility, the fund invests primarily in B2B technologies within sectors like ag tech, supply chain management, food preservation, and restaurant tech. Their portfolio includes forward-thinking companies such as Gastronomous, which automates commercial kitchen processes, and Izote Biosciences, a leader in bioscience for scalable fermentation. Based in Dallas, Toronto, and St. Louis, Redstick targets pre-seed and seed-stage startups across North America. They focus on businesses with a mission to enhance food production efficiency and streamline operations across the supply chain. Their investment strategy emphasizes support for founders with big ideas, providing hands-on guidance from an expert team that blends experience in food, manufacturing, and robotics. Redstick often serves as a strategic partner, offering expertise to help founders overcome early-stage challenges. The firm is led by Cam Crowder, a former Tim Horton’s franchisee, and Shane Larisey, an international hardware entrepreneur. They are supported by a diverse group of venture partners and advisors, ranging from product commercialization to B2B SaaS and robotics experts. Redstick prefers direct outreach through its Decile Hub platform, seeking entrepreneurs who align with their mission to revolutionize the food system.

Refactor Capital, founded in 2016 by Zal Bilimoria, is a seed-stage venture capital firm based in Burlingame, California. The fund primarily focuses on bio, climate, and hard tech innovations, aiming to support startups that tackle fundamental human and planetary health challenges. Notable investments include Solugen, Astranis, and Notable Labs, showcasing their dedication to transformative technologies in fields like sustainable chemicals, space, and healthcare. Refactor Capital typically leads or co-leads seed rounds, with investment amounts ranging from $1M to $2M. The firm values quick decision-making and close founder relationships, providing extensive support beyond capital, such as CFO services, communications training, and mental fitness resources. This hands-on approach is integral to their strategy, ensuring startups receive comprehensive guidance and resources. Geographically, Refactor Capital focuses on the U.S., with a significant portion of their portfolio companies based in California. They prefer to invest in startups that demonstrate clear potential to disrupt and innovate within heavily regulated industries, making technologies more accessible and efficient. Zal Bilimoria, the solo partner of Refactor Capital, brings a wealth of experience from his time at Andreessen Horowitz and major tech companies like Google, Netflix, and LinkedIn. His leadership and deep industry connections make Refactor Capital a formidable player in the early-stage investment landscape.

Regeneration.VC is an early-stage venture capital firm based in Los Angeles, focused on supercharging consumer-powered climate innovation. Founded in 2020, the firm targets companies that drive sustainability through circular and regenerative business models. Regeneration.VC invests in businesses across three core themes: Design, Use, and Reuse, aiming to redefine how products are created, utilized, and recycled. The firm’s investment strategy emphasizes companies that offer innovative solutions to pressing environmental challenges, particularly in sectors like next-gen materials, sustainable fashion, food and beverage, and reverse logistics. Regeneration.VC uses a rigorous multi-factor system to assess the circular and regenerative potential of potential investments, ensuring that their portfolio companies contribute meaningfully to the reduction of waste and carbon emissions. Regeneration.VC is supported by a diverse team of industry veterans, entrepreneurs, and impact investors, including high-profile figures like Leonardo DiCaprio, who actively contribute to the firm’s mission. This expertise allows the firm to provide more than just capital; they offer strategic guidance, networking opportunities, and operational support to help portfolio companies scale effectively and sustainably. The firm’s portfolio includes innovative companies like Cruz Foam, which produces compostable alternatives to polystyrene, and Greyparrot, an AI-powered waste management platform. With a growing fund and a strong commitment to driving positive environmental impact, Regeneration.VC is at the forefront of the consumer ClimateTech movement, helping to build a more sustainable and circular economy.

Regeneration.VC is a Los Angeles-based venture capital firm dedicated to supercharging consumer-powered climate innovation. The firm is deeply committed to driving the shift from a linear economy to one grounded in circular and regenerative principles. Their investment strategy revolves around three key themes: Design, focusing on systems and materials inspired by nature; Use, which supports circular brands and products; and Reuse, which promotes technologies that repurpose materials and extend product life cycles. Notable portfolio companies include Cruz Foam, which develops compostable alternatives to Styrofoam, and Greyparrot, an AI-powered platform for material recovery. Regeneration.VC’s approach is highly impact-driven, leveraging a proprietary multi-factor system to assess the circular and regenerative potential of early-stage companies. The firm is supported by a team of industry leaders and strategic advisors, including Leonardo DiCaprio, who plays a pivotal role in guiding the fund's mission to address global environmental challenges. Regeneration.VC has raised significant attention and capital, including a $45 million inaugural fund, to support its mission of transforming consumer industries and fostering a sustainable future.

Reinforced Ventures is a Pittsburgh-based venture capital firm that focuses on early-stage investments in deep tech sectors such as robotics, AI, autonomous systems, and biotechnology. Founded in 2019 by Euan Guttridge, the firm actively backs innovative startups leveraging cutting-edge technologies to disrupt industries and solve complex problems. Reinforced Ventures often leads seed and early-stage rounds, targeting companies developing novel solutions in industries like aerospace, mobility, and life sciences. The firm has a strong portfolio, including companies like DAGsHub (a platform for data scientists), Electric Sheep Robotics (offering autonomy-as-a-service for lawn care), and Lemurian Labs (developing solutions for autonomous edge systems). Their geographic focus includes North America and select global markets, with investments spanning key hubs like Pittsburgh, San Francisco, and Toronto. Reinforced Ventures’ strategy centers on investing in scalable companies that combine hardware and software innovations, particularly those addressing critical challenges in automation, AI, and biotech. With over 65 investments, they continue to partner with visionary founders to accelerate technological advancements.

Remiges Ventures is a US-Japan cross-border life-sciences venture capital firm founded in 2014 with offices in Seattle, Washington and Tokyo, Japan. The firm invests in early-stage drug discovery and therapeutic development companies and is distinguished by deep connections to Japanese academic medical research and the Japanese pharmaceutical industry, giving portfolio companies strategic access to Japanese partnering, clinical development pathways, and licensing opportunities alongside US and global scale. Remiges is led by Founder, Managing Partner and Managing Director Taro Inaba and is a SEC-registered investment adviser. Remiges has raised two biopharma funds. Remiges BioPharma Fund II closed in April 2021 at a final $95 million and attracted a strategic LP base including Taiho Pharmaceutical, Sumitomo Dainippon Pharma, Bristol-Myers Squibb, 1Globe Capital, EA Pharma, and Senju Pharmaceutical. The firm makes minority investments at seed, early-stage, and later-stage rounds, typically alongside strategic pharma syndicates. Alongside its investment activity, Remiges launched RDiscovery, a life-sciences incubator focused on advancing early-stage therapeutic concepts through company creation. The portfolio has expanded to 15 active companies. Notable investments include Glycomine (PMM2-CDG Phase 2 therapeutic, where Remiges led a Series C follow-on in April 2025), Restore Vision (Series A with first-in-human data in 2024), Eurus Therapeutics, Ride Health, KUPANDO, and Capacity Bio. The firm made 2 new investments in 2024 and at least 2 in 2025. Remiges occupies a distinct cross-border niche: its pharma LP base creates structural alignment between investor interests and portfolio company commercial development, while its Tokyo presence provides a genuine channel to Japanese clinical partnerships that pure US-based life-sciences funds cannot replicate.

Renaissance Venture Capital Fund (RVCF) is a first-of-its-kind Michigan-focused venture capital fund of funds headquartered in Ann Arbor, Michigan and established in 2008. The firm was built on the thesis that Michigan — despite ranking in the top 10 US states for R&D capacity per the Milken Institute's 2022 index — is chronically underserved by venture capital relative to its innovation output. RVCF closes that gap by investing as a limited partner in national venture capital firms committed to deploying capital into Michigan or Michigan-connected companies, while simultaneously bridging those funds to the regional startup community and Michigan's established corporate LP base. The fund is led by Founder, CEO, and Managing Partner Chris Rizik alongside Partner Jeff Rinvelt. Across five vintages — Fund I (2008), Fund II, Fund III ($81 million), Fund IV ($77.5 million, closed July 2021), and Fund V (active, with a Michigan Department of Treasury commitment in February 2025) — Renaissance has raised more than $280 million of LP capital and facilitated over $3 billion of venture investment into Michigan. The current portfolio comprises LP positions in 60-plus top-tier venture capital funds across all sectors and stages — IT, SaaS, healthtech, life sciences, industrial technology, mobility, and clean tech — with more than 800 active underlying portfolio companies. By design, Renaissance does not make direct startup investments. Its function is fund-of-funds allocation, founder connectivity, and ecosystem-building at the regional level. The model has successfully attracted top-tier coastal managers to commit dedicated capital to Michigan, creating a more durable and distributed talent and capital infrastructure than any single direct-investment vehicle could achieve.

Renegade Partners is a Bay Area-based venture capital firm, founded by Renata Quintini and Roseanne Wincek in 2020, with a focus on Series A investments. Renegade aims to back "audacious founders" working on transformative technologies, helping them build lasting, industry-defining companies. With a concentrated portfolio approach, the firm typically writes checks up to $10 million and is deeply involved in supporting startups during their critical growth phase, just after achieving product-market fit. Renegade Partners prioritizes not just financial backing but also strategic operational support. The firm has a unique emphasis on people operations, helping founders build strong teams that can scale effectively. With a commitment to long-term partnerships, Renegade actively participates on the boards of 80% of its portfolio companies, working closely with founders to navigate challenges and accelerate growth. The firm has raised two funds, including a recently closed $128 million second fund, bringing its total assets under management to $228 million. Renegade’s portfolio includes companies like Rootly, Copia Automation, Ansa, and Coda, all of which are pushing boundaries in their respective industries. Renegade Partners' approach is driven by a desire to create generational companies, focusing on the long game rather than short-term wins. This philosophy is reflected in the firm’s alignment with its founders and investors, ensuring that success is shared across the board.